Purchase Order 75N93025P00115

Award Date 11/25/24
Potential Completion Date 2/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, CA 94560, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $4,960 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company that specializes in RNA detection technologies. The contract is for the provision of reagent kits, which ACD supplies to support biomedical research efforts across various National Institutes of Health (NIH) institutes and other federal agencies. ACD's proprietary RNAscope technology and related...
This is a $15,515.60 firm-fixed-price purchase order contract awarded to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for the delivery of RNA probes. ACD is a molecular diagnostics company specializing in RNA detection technologies and has received numerous awards from various NIH institutes. This contract supports NIAID's biomedical research efforts, particularly in areas such as infectious diseases, by...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD) for the delivery of reagent kits. The contract has a ceiling value of $5,042.00 and an ultimate completion date of December 21, 2015. ACD is a molecular diagnostics company specializing in RNA detection technologies, and its proprietary RNAscope technology has been utilized in...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) on March 19, 2024. The $13,804.00 contract is for the delivery of ACD's RNAscope assay biological products, including kits, reagents, and probes, with a completion date of June 30, 2024. ACD is a for-profit manufacturer of diagnostic tools for personalized medicine applications and has...
This is a $13,793.20 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), a molecular diagnostics company specializing in RNA detection technologies. The contract is for the delivery of 12 custom RNAscope probes and an RNAscope fluorescent reagent kit, which will support various biomedical research efforts across NIAID and...
This firm-fixed-price purchase order, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Cell Diagnostics, Inc. (ACD), provides the RNASCOPE 2.5 VS REAGENT KIT, BROWN. The $8,037.20 contract is for the supply of ACD's proprietary RNA detection technology to support biomedical research efforts across various NIH institutes. As a subsidiary of Bio-Techne Corporation, ACD specializes in...
The federal contract award HHSN272201500399P was granted to Advanced Cell Diagnostics, Inc. (ACD) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $3,790 firm-fixed-price purchase order is for the provision of reagent kits and probes, with no set-aside designation. ACD is a molecular diagnostics company that specializes in RNA detection technologies, particularly its proprietary RNAscope platform. The company has...
This federal contract award, valued at $3,820.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics products. The contract is for the provision of reagents and supplies necessary for performing an assay on the Ventana Discovery Ultra Stainer. This purchase order contract is a firm-fixed-price arrangement with no...
This $20,120 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services' National Institutes of Health, to Advanced Cell Diagnostics, Inc. (doing business as ACD) for RNA SCOPE products and services. ACD, a subsidiary of Bio-Techne Corporation (doing business as Bio-Techne), will serve as the prime contractor. The contract period of performance spans from September 20, 2023 through...
This federal contract awards $34,976.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics, to provide the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases with various RNAscope kits and reagents. The contract is a firm-fixed-price purchase order with no set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, has a strong track record of providing these types of...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, awarded a firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) for $11,115.20. The award, identified as 75N93025P00115, is for the supply of an ACD product, the AMBIS #2249268, which represents ACD's proprietary RNAscope technology and related molecular diagnostics products. This technology enables the visualization and quantification of RNA biomarkers and has been utilized in various NIAID-funded research projects, including efforts related to infectious diseases and COVID-19. ACD, a subsidiary of Bio-Techne Corporation, is a manufacturer of specialized cell diagnostics and molecular pathology products. The contract does not have a set-aside designation. This award is likely part of NIAID's broader biomedical research initiatives, reflecting the agency's continued reliance on ACD's expertise in RNA detection technologies to support its intramural and extramural research programs.

Generated 11/21/24, 9:32 AM